PROVIDER STATEMENT

Provided by Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

Supported by an educational grant from Merck Sharp & Dohme LLC.

PROGRAM OVERVIEW

The treatment options for endometrial cancer (EC) have expanded in the last five years to include immunotherapy (IO) alone or combined with chemotherapy or tyrosine kinase inhibitors (TKIs), and DNA mismatch repair deficiency (dMMR) and microsatellite instability (MSI) have emerged as an actionable biomarker in advanced EC. These IO regimens have well-documented safety and efficacy. Obtaining optimal outcomes, therefore, necessitates a precision-medicine approach that tailors therapy based on patient and disease characteristics and incorporates the patient’s individual circumstances and personal wishes into the treatment planning process. Join EC expert Dr. Martina Murphy as she discusses the latest data and treatment options for patients with advanced EC, as well as adverse event considerations and management.

FACULTY CHAIR

Martina C. Murphy, MD Associate Professor of Medicine Director, UFCOM Introduction to Clinical Medicine 1A & 1B Program Director Hematology/Oncology Fellowship University of Florida Gainesville, Florida

CLINICAL CASE DEVELOPMENT FACULTY

Marilyn Huang MD, MS, FACOG Richard and Louise Crockett Endowed Professorship Professor and Director, Division of Gynecologic Oncology Department of Obstetrics & Gynecology University of Virginia Comprehensive Cancer Center Charlottesville, Virginia

Lindsey McAlarnen, MD, MSc Assistant Professor Division of Gynecological Oncology Department of Obstetrics and Gynecology University of Nebraska Medical Center Omaha, Nebraska

Release date: July 12, 2023 Expiration date: July 12, 2024 Estimated time to complete activity: 30 minutes

TARGET AUDIENCE

This educational activity has been designed to meet the needs of medical and gynecologic oncologists, advanced practice professionals, and fellows who treat and/or manage patients with endometrial cancer.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

Evaluate treatment options using patient and disease characteristics, plus integrate factors that contribute to improved patient quality of life
Monitor and mitigate treatment-related adverse events

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of July 12, 2023 through July 12, 2024, participants must:

Read the learning objectives
Complete the pretest
Study the educational activity
Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed posttest with a score of 66% or better and a completed activity evaluation form.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated. The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity: Marilyn Huang MD, MS, FACOG Advisory Board: Eisai, Immunogen, Natera, Seagen Grant Funding: Merck Honoraria: OncLive, Swedish Cancer Institute Lindsey McAlarnen, MD, MSc does not have any financial relationships or relationships to products or devices with ineligible companies. Martina Murphy, MD does not have any financial relationships or relationships to products or devices with ineligible companies. The Integrity Continuing Education, Inc. planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent) Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS Plug-in: Adobe^® Flash^® Player 10

Adobe^® Flash^® Player 10 plug-in should be downloaded
Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus

For optimal performance, the use of Internet Explorer below 8 is not recommended For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below: Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Cases from the Clinic: Focus on Endometrial Cancer